Fair Value Calculator Fair Value Calculator
EN DE

Tekcapital plc (TEKCF) Fair Value & Analysis

Financial Services · US · Market cap $17.0M

TP Tekcapital plc logo Tekcapital plc TEKCF · US
Price$0.0662
Fair Value$0.1300
Upside+96.4%
Quality32/100
Watch Tekcapital plc for free, get notified when fair value or trend changes. Watch for free
Evidence: Low Range $0.1000 – $0.1700

Fair value as of: Jun 24, 2026

From 2 valuation models · updated 23 days ago

Price vs Fair Value (12 months)

$0.1304 $0.0662 Fair Value $0.1300 Jul 2025 Jul 2026

12‑month range $0.0662 – $0.1304 · fair‑value band $0.1000 – $0.1700 · the $0.0662 price screens below the $0.1300 fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Tekcapital plc (TEKCF) currently trades at $0.0662, while our model-based Fair Value estimate is $0.1300, implying the stock looks roughly 96.4% undervalued today. We read business quality at 32/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Revenue declined 70.7% year over year. It earns a return on equity of -27.3%. Fundamentals as of Jun 24, 2026

Our scenario range runs from $0.1000 (bear case) to $0.1700 (bull case); at $0.0662, the current price sits below that range. The share trades about 49% below its 52-week high, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside, at 96%, TEKCF screens cheaper than that median.

Key figures & financial health

Revenue (TTM) −$15.2M
Revenue growth (YoY) -70.7%
Return on equity -27.3%
Free cash flow −$2.2M FY2025
Operating margin 105%
EPS (TTM) $-0.1000
More key figures
EPS growth (YoY) -73.4%
Net cash $530K FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

About the company

Tekcapital plc, together with its subsidiaries, provides technology transfer services to universities and corporate clients in the United Kingdom and the United States. It operates through two segments, Professional Services and Licensing and Investment Activities. The company offers Microsalt, that provides the flavor of salt with half of the sodium; and low-sodium salt and snack food. It also develops and sells smart eyewear under the Lucyd, Nautica, Eddie Bauer, and Reebok brands; provides baked food coating to reduce fat; and portable oxygen concentrators under the Belluscura brand. In addition, the company provides GenIP, a generative artificial intelligence (GenAI) analytic services to companies, research institutions, and venture funds; and Guident, a software platform that enables the remote monitoring and control of autonomous vehicles. Further, the company offers management services. Tekcapital plc was incorporated in 2014 and is based in London, the United Kingdom.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Tekcapital plc reported revenue of $286K in FY2025 versus $816K in FY2021, a compound −23.1%/yr. Reported net income was −$17.5M in FY2025.

Revenue −23.1%/yr
FY21 $816K
FY22 −$9.3M
FY23 $735K
FY24 $426K
FY25 $286K
Net income
FY21 $26.4M
FY22 −$11.8M
FY23 −$15.7M
FY24 $19.2M
FY25 −$17.5M

Is TEKCF fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Tekcapital plc Fair Value". https://www.fairvalue-calculator.com/stock/TEKCF

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
Fondul Proprietatea SA FP $4.20 $6.41 +53%
The Schiehallion Fund Limited MNTN $0.0214 $0.0400 +87%
BlackRock, Inc BLK $1,052 $465.03 -56%
Blackstone Inc BX $123.26 $52.88 -57%
BH Macro Limited BHMU $4.42 $8.84 +100%
Investor AB INVEB kr 388.65 kr 1,430 +268%
BioPharma Credit PLC BPCR $0.9600 $1.47 +53%
Brookfield Corporation BN $43.94 $9.95 -77%
KKR & Co KKR C$21.40 C$5.61 -74%
Brookfield Asset Management Ltd BAM C$63.81 C$41.56 -35%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Tekcapital plc (TEKCF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.1300 versus a price of $0.0662, about +96% (undervalued). Model-based estimate, not financial advice.
What is the fair value of TEKCF?
Our model-based fair value for Tekcapital plc is $0.1300 (as of Jun 24, 2026), built from audited fundamentals. The current price is $0.0662.
What is the quality score of TEKCF?
Tekcapital plc has a Quality Score of 32/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of TEKCF?
The net profit margin of Tekcapital plc is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Tekcapital plc analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.